Allosteric MAPKAPK2 Inhibitors Improve Plaque Stability in Advanced Atherosclerosis
Lale Özcan, Canan Kasikara, Arif Yurdagul, George Kuriakose, Brian K. Hubbard, Michael H. Serrano‐Wu, Ira A. Tabas
This study shows that MK2 inhibitors TBX-1 and TBX-2 improve glucose metabolism and reduce atherosclerotic plaque instability in mice with established atherosclerosis.
PLoS ONE · May 13, 2021Peer-reviewedMolecular Biology